Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient

Amy L. Kiskaddon; Michael Wilsey; Ignacio Gonzalez-Gomez; Jessica Laks; Alyssa Miles; Jennifer Carapellucci; Alfred Asante-Korang

doi:10.1111/petr.14443

Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient

Amy L. Kiskaddon, Michael Wilsey, Ignacio Gonzalez-Gomez, Jessica Laks, Alyssa Miles, Jennifer Carapellucci, Alfred Asante-Korang

Research output: Contribution to journal › Article › peer-review

Abstract

In pediatric patients who undergo heart transplantation, severe immune-mediated bowel disease has been reported. Management is complex, and there are little data discussing the use of basiliximab for immune-mediated bowel disease. This case report discusses a pediatric patient who developed immune-mediated bowel disease following heart transplantation and was successfully managed with basiliximab.

Original language	English (US)
Article number	e14443
Journal	Pediatric transplantation
Volume	27
Issue number	2
DOIs	https://doi.org/10.1111/petr.14443
State	Published - Mar 2023

Keywords

Russell body
basiliximab
immune-mediated bowel disease
pediatric heart transplant

ASJC Scopus subject areas

Transplantation
Pediatrics, Perinatology, and Child Health

Access to Document

10.1111/petr.14443

Cite this

@article{7a1faaa567dc4116b3f5b93c49dc8653,

title = "Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient",

abstract = "In pediatric patients who undergo heart transplantation, severe immune-mediated bowel disease has been reported. Management is complex, and there are little data discussing the use of basiliximab for immune-mediated bowel disease. This case report discusses a pediatric patient who developed immune-mediated bowel disease following heart transplantation and was successfully managed with basiliximab.",

keywords = "Russell body, basiliximab, immune-mediated bowel disease, pediatric heart transplant",

author = "Kiskaddon, {Amy L.} and Michael Wilsey and Ignacio Gonzalez-Gomez and Jessica Laks and Alyssa Miles and Jennifer Carapellucci and Alfred Asante-Korang",

note = "Publisher Copyright: {\textcopyright} 2022 Wiley Periodicals LLC.",

year = "2023",

month = mar,

doi = "10.1111/petr.14443",

language = "English (US)",

volume = "27",

journal = "Pediatric transplantation",

issn = "1397-3142",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient

AU - Kiskaddon, Amy L.

AU - Wilsey, Michael

AU - Gonzalez-Gomez, Ignacio

AU - Laks, Jessica

AU - Miles, Alyssa

AU - Carapellucci, Jennifer

AU - Asante-Korang, Alfred

PY - 2023/3

Y1 - 2023/3

N2 - In pediatric patients who undergo heart transplantation, severe immune-mediated bowel disease has been reported. Management is complex, and there are little data discussing the use of basiliximab for immune-mediated bowel disease. This case report discusses a pediatric patient who developed immune-mediated bowel disease following heart transplantation and was successfully managed with basiliximab.

AB - In pediatric patients who undergo heart transplantation, severe immune-mediated bowel disease has been reported. Management is complex, and there are little data discussing the use of basiliximab for immune-mediated bowel disease. This case report discusses a pediatric patient who developed immune-mediated bowel disease following heart transplantation and was successfully managed with basiliximab.

KW - Russell body

KW - basiliximab

KW - immune-mediated bowel disease

KW - pediatric heart transplant

UR - http://www.scopus.com/inward/record.url?scp=85142630220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142630220&partnerID=8YFLogxK

U2 - 10.1111/petr.14443

DO - 10.1111/petr.14443

M3 - Article

C2 - 36419214

AN - SCOPUS:85142630220

SN - 1397-3142

VL - 27

JO - Pediatric transplantation

JF - Pediatric transplantation

IS - 2

M1 - e14443

ER -

Basiliximab therapy for immune-mediated bowel disease in a pediatric heart transplant patient

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this